Latest stories on NVO
Novo Nordisk (NVO)’s Pediatric Obesity Opportunity Faces a Bigger Test
Yahoo Finance63 · neutralproduct/pr
Could This New Opportunity Be Worth Billions for Novo Nordisk?
The Motley Fool63 · neutralgeneral
4 stocks to watch on Friday: KR, NVO, AVGO, and SPCX
Business Insider50 · neutralgeneral
Novo Nordisk falls as Morgan Stanley cuts rating to Underweight on semaglutide concern
Seeking Alpha38 · neutralanalyst
NVO Stock: Why Morgan Stanley Is Bearish On Novo Nordisk Despite Its Weight-Loss Drug Opportunity
Stocktwits News38 · neutralanalyst
Novo Nordisk downgraded to Underweight from Equal Weight at Morgan Stanley
The Fly38 · neutralanalyst
Why is Novo Nordisk stock sliding today?
Investing.com Markets42 · neutralgeneral
Morgan Stanley cuts Novo Nordisk on growth, patent cliff concerns; shares dip
Investing.com Markets38 · neutralanalyst
Morgan Stanley downgrades Novo Nordisk stock rating on growth concerns
Investing.com Analyst Ratings38 · neutralanalyst
Novo Nordisk: Valuation Reflects High Risk, But Solid Margin Of Safety
Seeking Alpha73 · bullishanalyst
AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool54 · neutralanalyst
Novo Nordisk price target raised to DKK 320 from DKK 300 at HSBC
The Fly61 · neutralanalyst
Novo Nordisk says Wegovy approved in China for liver disease MASH
Reuters67 · bullishproduct/pr
Can Oral Wegovy Help Novo Nordisk Capture China’s $4.46 Billion GLP-1 Opportunity?
Yahoo Top73 · bullishproduct/pr
GLP1 Drugs Work for Kids, Says Novo Nordisk. They Could Be Another Huge Market.
Barron's73 · bullishproduct/pr
Is Novo Nordisk Stock Still Too Cheap for Investors to Ignore?
Yahoo Top64 · neutralanalyst
Is Novo Nordisk Stock Still Too Cheap for Investors to Ignore?
The Motley Fool64 · neutralanalyst
Novo Nordisk: STEP Young Wins, But Heart Trials Just Got Halted (Rating Downgrade)
Seeking Alpha38 · neutralgeneral
Wall Street Breakfast Podcast: Canada's Tariffs Go Live
Seeking Alpha54 · neutralgeo/war
3 of the Best Growth Stocks to Buy for Less Than $100 Right Now
Yahoo Finance57 · neutralanalyst
3 of the Best Growth Stocks to Buy for Less Than $100 Right Now
The Motley Fool57 · neutralanalyst
Novo Nordisk faces fresh setback as it halts two heart drug trials
Seeking Alpha34 · bearishproduct/pr
Novo Nordisk reports positive semaglutide trial results in young children
Seeking Alpha73 · bullishproduct/pr
Eli Lilly vs. Novo Nordisk: One Has 39% Upside. I'm Picking the Other.
Yahoo Finance56 · neutralanalyst